Inventor · disambiguated record
Michel Maillard
Also filed as: MAILLARD MICHEL · MAILLARD MICHEL G
14 granted patents·11 pending applications·307 citations·filing 1994–2009
93Inventor score
Top patents by PatentIndex Score
25 records- 0194US7176242B2N,N′-substituted-1,3-diamino-2-hydroxypropane derivativesUPJOHN CO·Filed 2002·Granted Feb 13, 2007·92 cites·20 claims
- 0289US7727997B2N,N′-substituted-1,3-diamino-2-hydroxypropane derivativesELAN PHARM INC·Filed 2006·Granted Jun 1, 2010·21 cites·27 claims
- 0389US7312360B2Substituted hydroxyethylaminesELAN PHARM INC·Filed 2002·Granted Dec 25, 2007·39 cites·11 claims
- 0485US5861405AS-substituted 1,3,7-trialkyl-xanthine derivativesUS HEALTH·Filed 1994·Granted Jan 19, 1999·34 cites·28 claims
- 0582US7385085B2Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitorsELAN PHARM INC·Filed 2005·Granted Jun 10, 2008·6 cites·10 claims
- 0682US7244725B2Acetyl 2-hydroxy-1, 3-diaminoalkanesUPJOHN CO·Filed 2003·Granted Jul 17, 2007·16 cites·14 claims
- 0782US7214715B2Compounds to treat Alzheimer's diseaseELAN PHARM INC·Filed 2001·Granted May 8, 2007·18 cites·100 claims
- 0880US7858642B2Substituted hydroxyethylamine aspartyl protease inhibitorsELAN PHARM INC·Filed 2009·Granted Dec 28, 2010·5 cites·24 claims
- 0980US6846813B2Compounds to treat alzheimer's diseaseUPJOHN CO·Filed 2001·Granted Jan 25, 2005·10 cites·72 claims
- 1079US5620676ABiologically active ATP analogsUS ARMY·Filed 1995·Granted Apr 15, 1997·55 cites·34 claims
- 1171US7645780B2Acetyl 2-hydroxy-1, 3-diaminoalkanesELAN PHARM INC·Filed 2006·Granted Jan 12, 2010·1 cites·14 claims
- 1261US7361688B2Substituted aminoalcohols useful in treatment of Alzheimer's diseaseELAN PHARM INC·Filed 2002·Granted Apr 22, 2008·1 cites·9 claims
- 1358US2010145056A1Acetyl 2-hydroxy-1,3-diaminoalkanesJOHN VARGHESE·Filed 2009·Application pending·0 cites
- 1456US5498605ASulfo-derivatives of adenosineUS ARMY·Filed 1994·Granted Mar 12, 1996·9 cites·21 claims
- 1556US2009042961A1Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitorsELAN PHARM INC·Filed 2008·Application pending·0 cites
- 1655US2008096942A1Substituted HydroxyethylaminesUPJOHN CO·Filed 2007·Application pending·0 cites
- 1752US2006154926A1Methods of treating alzheimer's disease using aryl alkanoic acid amidesELAN PHARM INC·Filed 2003·Application pending·0 cites
- 1851US2009074746A1Compounds to treat alzheimer's diseaseALZHEIMER S COLLABORATION·Filed 2004·Application pending·0 cites
- 1948US2007213407A1Compounds to treat Alzheimer's diseaseELAN PHARMACEUTICALS AND PHARM·Filed 2006·Application pending·0 cites
- 2047US2006089355A1Methods of treating alzheimer's disease using aromatically substituted w-amino-alkanoic acid amides and alkanoic acid diamidesMAILLARD MICHEL·Filed 2003·Application pending·0 cites
- 2142US7498436B2Substituted hydroxyethylaminesPHARMACIA & UPJOHN CO LLC·Filed 2003·Granted Mar 3, 2009·0 cites·7 claims
- 2242US2005239836A1Substituted hydroxyethylamine aspartyl protease inhibitorsJOHN VARGHESE·Filed 2005·Application pending·0 cites
- 2337US2005261273A1Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitorsJOHN VARGHESE·Filed 2005·Application pending·0 cites
- 2435US2005239832A1Methods of treatment of amyloidosis using bi-cyclic aspartyl protease inhibitorsJOHN VARGHESE·Filed 2005·Application pending·0 cites
- 2534US2005239790A1Substituted hydroxyethylamine aspartyl protease inhibitorsJOHN VARGHESE·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michel Maillard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →